ATE228566T1 - Verfahren zur herstellung von fusionsproteinen - Google Patents
Verfahren zur herstellung von fusionsproteinenInfo
- Publication number
- ATE228566T1 ATE228566T1 AT96113414T AT96113414T ATE228566T1 AT E228566 T1 ATE228566 T1 AT E228566T1 AT 96113414 T AT96113414 T AT 96113414T AT 96113414 T AT96113414 T AT 96113414T AT E228566 T1 ATE228566 T1 AT E228566T1
- Authority
- AT
- Austria
- Prior art keywords
- dna sequence
- transfected
- fusion proteins
- restriction site
- splice site
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
- C07K16/462—Igs containing a variable region (Fv) from one specie and a constant region (Fc) from another
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40988989A | 1989-09-20 | 1989-09-20 | |
EP90913419A EP0493418B1 (de) | 1989-09-20 | 1990-08-01 | Verfahren zur herstellung von fusionsproteinen |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE228566T1 true ATE228566T1 (de) | 2002-12-15 |
Family
ID=23622388
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96113414T ATE228566T1 (de) | 1989-09-20 | 1990-08-01 | Verfahren zur herstellung von fusionsproteinen |
AT90913419T ATE152174T1 (de) | 1989-09-20 | 1990-08-01 | Verfahren zur herstellung von fusionsproteinen |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT90913419T ATE152174T1 (de) | 1989-09-20 | 1990-08-01 | Verfahren zur herstellung von fusionsproteinen |
Country Status (9)
Country | Link |
---|---|
EP (2) | EP0493418B1 (de) |
JP (1) | JP3051162B2 (de) |
AT (2) | ATE228566T1 (de) |
AU (1) | AU633357B2 (de) |
CA (1) | CA2066612C (de) |
DE (2) | DE69034022T2 (de) |
DK (2) | DK0765937T3 (de) |
ES (2) | ES2187598T3 (de) |
WO (1) | WO1991004329A1 (de) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5116964A (en) * | 1989-02-23 | 1992-05-26 | Genentech, Inc. | Hybrid immunoglobulins |
US5225538A (en) * | 1989-02-23 | 1993-07-06 | Genentech, Inc. | Lymphocyte homing receptor/immunoglobulin fusion proteins |
US6406697B1 (en) | 1989-02-23 | 2002-06-18 | Genentech, Inc. | Hybrid immunoglobulins |
US5498538A (en) * | 1990-02-15 | 1996-03-12 | The University Of North Carolina At Chapel Hill | Totally synthetic affinity reagents |
US5747334A (en) * | 1990-02-15 | 1998-05-05 | The University Of North Carolina At Chapel Hill | Random peptide library |
ATE220113T1 (de) * | 1990-10-22 | 2002-07-15 | Genentech Inc | Verfahren zur modifizierung von dna und zur detektion der wirkungen auf die interaktion von modifizierten polypeptiden und zielsubstraten |
US5525491A (en) * | 1991-02-27 | 1996-06-11 | Creative Biomolecules, Inc. | Serine-rich peptide linkers |
US6103521A (en) * | 1995-02-06 | 2000-08-15 | Cell Genesys, Inc. | Multispecific chimeric receptors |
US5723125A (en) * | 1995-12-28 | 1998-03-03 | Tanox Biosystems, Inc. | Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide |
ATE317011T1 (de) * | 1999-07-12 | 2006-02-15 | Genentech Inc | Expressionsvektoren und anwendungsmethoden |
JP4793971B2 (ja) | 1999-08-09 | 2011-10-12 | メルク パテント ゲーエムベーハー | 複合サイトカイン−抗体複合体 |
US20030133939A1 (en) | 2001-01-17 | 2003-07-17 | Genecraft, Inc. | Binding domain-immunoglobulin fusion proteins |
US7754208B2 (en) | 2001-01-17 | 2010-07-13 | Trubion Pharmaceuticals, Inc. | Binding domain-immunoglobulin fusion proteins |
PT1366067E (pt) * | 2001-03-07 | 2012-11-29 | Merck Patent Gmbh | Tecnologia de expressão para proteínas contendo uma unidade de anticorpo de isotipo híbrido |
US6992174B2 (en) | 2001-03-30 | 2006-01-31 | Emd Lexigen Research Center Corp. | Reducing the immunogenicity of fusion proteins |
DK1706428T3 (da) | 2004-01-22 | 2009-11-30 | Merck Patent Gmbh | Anti-cancer-antistoffer med reduceret komplementfiksering |
EP1912675B1 (de) | 2005-07-25 | 2014-02-12 | Emergent Product Development Seattle, LLC | B-zell-verringerung mit cd37-spezifischen und cd20-spezifischen bindungsmolekülen |
ES2384055T3 (es) | 2005-12-30 | 2012-06-28 | Merck Patent Gmbh | Variantes de la interleucina-12p40 con estabilidad mejorada |
JP2009521912A (ja) | 2005-12-30 | 2009-06-11 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | 低減された免疫原性を有する抗cd19抗体 |
EP2041178A2 (de) | 2006-06-12 | 2009-04-01 | Trubion Pharmaceuticals, Inc. | Multivalente einzelkettenbindungsproteine mit effektorfunktion |
PT2132228E (pt) | 2008-04-11 | 2011-10-11 | Emergent Product Dev Seattle | Imunoterapia de cd37 e sua combinação com um quimioterápico bifuncional |
GB201403775D0 (en) | 2014-03-04 | 2014-04-16 | Kymab Ltd | Antibodies, uses & methods |
US10071748B2 (en) | 2015-09-17 | 2018-09-11 | Sony Corporation | System and method for providing driving assistance to safely overtake a vehicle |
AU2016326449A1 (en) | 2015-09-21 | 2018-03-22 | Aptevo Research And Development Llc | CD3 binding polypeptides |
US9567399B1 (en) | 2016-06-20 | 2017-02-14 | Kymab Limited | Antibodies and immunocytokines |
WO2018083248A1 (en) | 2016-11-03 | 2018-05-11 | Kymab Limited | Antibodies, combinations comprising antibodies, biomarkers, uses & methods |
CN110592057B (zh) * | 2019-09-27 | 2022-01-28 | 昆明理工大学 | 嵌合裂解酶ILTphg和编码此酶的多核苷酸 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4771002A (en) * | 1984-02-24 | 1988-09-13 | Lubrizol Genetics, Inc. | Transcription in plants and bacteria |
-
1990
- 1990-08-01 DE DE69034022T patent/DE69034022T2/de not_active Expired - Fee Related
- 1990-08-01 WO PCT/US1990/004301 patent/WO1991004329A1/en active IP Right Grant
- 1990-08-01 DK DK96113414T patent/DK0765937T3/da active
- 1990-08-01 ES ES96113414T patent/ES2187598T3/es not_active Expired - Lifetime
- 1990-08-01 AT AT96113414T patent/ATE228566T1/de not_active IP Right Cessation
- 1990-08-01 AT AT90913419T patent/ATE152174T1/de not_active IP Right Cessation
- 1990-08-01 DK DK90913419.9T patent/DK0493418T3/da active
- 1990-08-01 DE DE69030579T patent/DE69030579T2/de not_active Expired - Fee Related
- 1990-08-01 ES ES90913419T patent/ES2103274T3/es not_active Expired - Lifetime
- 1990-08-01 AU AU63352/90A patent/AU633357B2/en not_active Ceased
- 1990-08-01 EP EP90913419A patent/EP0493418B1/de not_active Expired - Lifetime
- 1990-08-01 JP JP2512474A patent/JP3051162B2/ja not_active Expired - Fee Related
- 1990-08-01 CA CA002066612A patent/CA2066612C/en not_active Expired - Lifetime
- 1990-08-01 EP EP96113414A patent/EP0765937B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP3051162B2 (ja) | 2000-06-12 |
CA2066612C (en) | 1998-12-08 |
CA2066612A1 (en) | 1991-03-21 |
WO1991004329A1 (en) | 1991-04-04 |
EP0493418B1 (de) | 1997-04-23 |
DE69030579D1 (de) | 1997-05-28 |
DE69034022D1 (de) | 2003-01-09 |
ES2187598T3 (es) | 2003-06-16 |
ES2103274T3 (es) | 1997-09-16 |
AU633357B2 (en) | 1993-01-28 |
DE69034022T2 (de) | 2003-07-10 |
EP0493418A4 (en) | 1992-09-02 |
JPH05500310A (ja) | 1993-01-28 |
DK0765937T3 (da) | 2003-03-24 |
EP0493418A1 (de) | 1992-07-08 |
EP0765937B1 (de) | 2002-11-27 |
EP0765937A1 (de) | 1997-04-02 |
DE69030579T2 (de) | 1997-11-13 |
AU6335290A (en) | 1991-04-18 |
ATE152174T1 (de) | 1997-05-15 |
DK0493418T3 (da) | 1997-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE152174T1 (de) | Verfahren zur herstellung von fusionsproteinen | |
AU2894289A (en) | Domain-modified constant region antibodies | |
MY157028A (en) | Mammalian cytokine, related reagents | |
DE68929453D1 (de) | Osteogene Vorrichtungen | |
NL300197I1 (de) | ||
PT83065A (de) | Fusionsproteine verfahren zu ihrer herstellung und ihre verwendung | |
YU150891A (sh) | Rekombinantna genetska informacija | |
FI864624A (fi) | Bombyx morin nuclear polyhedrosis -yhdistelmävirus ja menetelmiä proteiinien valmistamiseksi tätä käyttäen | |
DK0646646T3 (da) | System til ekspression af Lck-protein | |
DE3683447D1 (de) | Verfahren zur herstellung von humanlysozym. | |
AU6989687A (en) | Preparation of factor XIIIa by gene manipulation | |
ATE265533T1 (de) | Saeugetierchemokine | |
PT97427A (pt) | Processo para a preparacao de proteinas de fusao de tendamistato em estreptomicetas | |
MX9603266A (es) | Genes de timocina de mamiferos. | |
DE59712771D1 (de) | Nebenhoden-spezifisches Rezeptorprotein und dessen Verwendung | |
PT81253B (pt) | Processo para a preparacao de uma sequencia de sinal sintetica para o transporte de proteinas em sistemas de expressao | |
NO173194C (no) | Fremgangsmaate for fremstilling av proinsulin | |
WO2000034335A3 (en) | 'death domain' containing receptors | |
AR002004A1 (es) | Proteina slam, anticuerpo o un fragmento del mismo que se fija a dicha proteina, metodo de purificacion, acido nucleico que codifica dicha proteina,vector de expresion, equipo que la contiene, metodo de deteccion, metodo de modulacion y metodo para preparar una composicion farmaceutica. | |
DE68917520D1 (de) | Verfahren und Systeme zur Herstellung von HIV-Antigenen. | |
KR890013177A (ko) | 신규폴리펩티드 및 그것을 코우드하는 dna | |
AU596692B2 (en) | DNA coding for antigen protein of rinderpest virus | |
DK0487229T3 (da) | DNA, der koder for et protein, som binder til enhanceren for alfa-føtoproteingenet |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0765937 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |